Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113980053A discloses novel chiral thioether-phosphine ligands enabling efficient palladium-catalyzed asymmetric allylic alkylation with high yields.
Novel dihalide-to-acid route eliminates toxic cyanide, offering cost-effective Repaglinide intermediate manufacturing with high purity.
Patent CN111592560A reveals a robust route for ACDB, offering high singlet oxygen yield for photodynamic therapy applications and supply chain stability.
Patent CN116102517B reveals a one-step synthesis method offering high purity and reduced toxicity for reliable agrochemical intermediate supply chains.
Patent CN100491387C introduces an air-stable ferrocenyl palladacycle for Suzuki coupling, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel ligand-free CuCl catalyzed trifluoromethylation method offers cost reduction and scalable production for pharmaceutical intermediates supply chain.
Novel ligand-free CuCl catalyzed method offers high selectivity and scale-up potential for pharmaceutical intermediates reducing cost and improving supply chain reliability significantly.
Patent CN104496749B reveals a high-selectivity method for substituted cinnamyl alcohol using nanoporous gold. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN112110837B details a transition-metal-free method for organic sulfone synthesis, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN103922934A reveals cost-effective inorganic alkali alkylation. Enhances supply chain reliability and reduces manufacturing costs for intermediates.
Patent CN104496749B reveals nanoporous gold catalyst method for high-purity substituted cinnamyl alcohol. Offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel catalytic route for 4-trifluoromethyl nicotinic acid production. Reduces toxicity and improves yield for Flonicamid intermediates via mild oxidation.
Patent CN118026832A reveals one-step catalytic oxidation for high-purity halogenated anthraquinone intermediates reducing environmental impact and manufacturing costs significantly.
Patent CN121517422A reveals mixed acid catalysis for high-purity hexacyclopropyl hexaazaisowurtzitane. Enhances safety and yield for pharmaceutical intermediate manufacturing.
Patent CN108950592A enables green electrochemical route for aryl sulfinates. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107162932B reveals a one-step benzonitrile synthesis using ionic liquids. Achieve high purity, reduced corrosion, and scalable manufacturing for pharmaceutical intermediates.
Patent CN105218600B reveals a high-yield synthesis route for mannose derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107382769A reveals a low-cost synthesis for trifluoro butene intermediates. This method offers significant supply chain stability and cost reduction advantages.
Patent CN113292426A details a high-yield methanol-based reduction process for ethyl 3-hydroxy-4-chlorobutyrate, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN115710226A reveals a safer 9-chloroacridine synthesis via vacuum distillation, eliminating ice-water quenching risks and reducing three wastes significantly.